Thyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study
Authors:
- Masafumi KurajohMKMasafumi Kurajoh
- Akiyo YamasakiAYAkiyo Yamasaki
- Toshiki NagasakiTNToshiki Nagasaki
- Yuki NagataYNYuki Nagata
- Shinsuke YamadaSYShinsuke Yamada
- Yasuo ImanishiYIYasuo Imanishi
- Masanori EmotoMEMasanori Emoto
- Kanae TakahashiKTKanae Takahashi
- Kouji YamamotoKYKouji Yamamoto
- Ayumi ShintaniASAyumi Shintani
- Masaaki InabaMIMasaaki Inaba
Open Access
- 5 July 2019
- journal article
- research article
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 19 (1) , 1-7
Abstract
We examined whether inferior thyroid artery peak systolic velocity (ITA-PSV) predicts an increase in levothyroxine (LT4) dosage in pregnant women with Hashimoto’s thyroiditis. Twenty-two women with Hashimoto’s thyroiditis who were planning and later achieved pregnancy or confirmed as pregnant were enrolled in this retrospective longitudinal observational study. ITA-PSV and thyroid volume were measured using ultrasonography. Serum concentrations of free thyroxine (F-T4), free triiodothyronine (F-T3), and thyroid stimulating hormone (TSH) were simultaneously determined. We adjusted LT4 dosage to maintain serum TSH at < 2.5 μIU/mL (1st trimester) and later at < 3 μIU/mL (2nd, 3rd trimester). Eighteen patients (81.8%) required an increase in LT4 dosage during pregnancy, of whom 7 (31.8%) required an increase ≥50 μg. Multivariable regression analysis showed that TSH (β = 0.507, p = 0.008) and ITA-PSV (β = − 0.362, p = 0.047), but not thyroid volume, F-T4, or F-T3, were independently associated with increased LT4 dosage. Receiver-operating characteristic analysis for predicting an increase in LT4 ≥ 50 μg/day showed that the area under the curve (0.905) for ITA-PSV with TSH was not significantly increased (p = 0.123) as compared to that (0.743) for TSH alone, whereas integrated discrimination improvement was significantly increased (27.9%, p = 0.009). In pregnant patients with Hashimoto’s thyroiditis, ITA-PSV was a significant predictor of increase in LT4 dosage independent of TSH level, while ITA-PSV plus TSH showed significantly improved predictability as compared to TSH alone. These results suggest that ITA-PSV reflects residual thyroid function and is useful for evaluating the need for increased thyroid hormone production in pregnant patients with Hashimoto’s thyroiditis.Keywords
This publication has 18 references indexed in Scilit:
- Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and PostpartumThyroid®, 2011
- The Relationship of Preconception Thyrotropin Levels to Requirements for Increasing the Levothyroxine Dose During Pregnancy in Women with Primary HypothyroidismThyroid®, 2010
- The Magnitude of Increased Levothyroxine Requirements in Hypothyroid Pregnant Women Depends upon the Etiology of the HypothyroidismThyroid®, 2009
- Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' diseaseBiomedicine & Pharmacotherapy, 2007
- The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves’ disease relapseClinical Endocrinology, 2005
- Subclinical Hypothyroidism and Pregnancy OutcomesObstetrics & Gynecology, 2005
- Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with HypothyroidismNew England Journal of Medicine, 2004
- Overt and Subclinical Hypothyroidism Complicating PregnancyThyroid®, 2002
- Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the ChildNew England Journal of Medicine, 1999
- Increased Need for Thyroxine during Pregnancy in Women with Primary HypothyroidismNew England Journal of Medicine, 1990